Feb 19, 2026 09:45AM

Feb 19, 2026 07:55AM

Jan 9, 2026 08:01AM

Jan 6, 2026 04:33AM

Dec 8, 2025 07:32AM

Nov 6, 2025 04:22AM

Nov 5, 2025 03:59PM NewAmsterdam Pharma Co NV (NAMS) PT Raised to $44 at RBC Capital

Oct 20, 2025 07:08AM

Oct 6, 2025 04:32AM

Aug 25, 2025 05:13AM

Aug 18, 2025 08:02AM

Aug 11, 2025 08:23AM

Aug 6, 2025 10:18AM

Jul 30, 2025 08:26AM NewAmsterdam Pharma reports reduction in Alzheimer's biomarkers in trial

Jul 17, 2025 06:30AM

Jun 17, 2025 05:18AM

Jun 12, 2025 07:22AM

Jun 12, 2025 07:15AM

Jun 9, 2025 04:06PM

Jun 9, 2025 07:05AM

Jun 4, 2025 06:53AM Cantor Fitzgerald Starts NewAmsterdam Pharma Co NV (NAMS) at Overweight

Jun 3, 2025 05:52AM

May 7, 2025 07:15AM

Apr 17, 2025 04:02PM

Feb 27, 2025 07:18AM

Jan 13, 2025 12:50PM

Jan 10, 2025 08:03AM

Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies

Dec 30, 2024 06:06AM

Dec 11, 2024 07:15AM

Dec 10, 2024 04:36PM

Dec 10, 2024 07:00AM

Nov 20, 2024 04:10PM

Nov 20, 2024 07:01AM

Nov 19, 2024 07:57AM Piper Sandler Reiterates Overweight Rating on NewAmsterdam Pharma Co NV (NAMS)

Oct 21, 2024 07:14AM

Sep 23, 2024 07:20AM

Sep 7, 2024 08:00PM

Aug 27, 2024 08:18AM

Jul 29, 2024 08:06AM

Jul 26, 2024 04:01PM

Jul 18, 2024 08:06AM NewAmsterdam Pharma (NAMS) Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All